Page 1 of Clinical Trials for Xenon Pharmaceuticals Inc. [SPONSOR-COLLABORATORS], 5 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM)
Last Updated: March 14, 2012
Condition(s): Primary Erythromelalgia; Inherited Erythromelalgia
2
Completed
A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia
Last Updated: December 1, 2011
Condition(s): Postherpetic Neuralgia
3
Active, not recruiting
Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia
Last Updated: March 14, 2012
Condition(s): Primary Erythromelalgia; Inherited Erythromelalgia
4
Completed
Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
Last Updated: May 28, 2010
Condition(s): Dental Pain
5
Completed
Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers
Last Updated: September 10, 2009
Condition(s): Healthy Human Volunteers

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Xenon+Pharmaceuticals+Inc.

Page 1 of Clinical Trials for Xenon Pharmaceuticals Inc. [SPONSOR-COLLABORATORS], 5 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About